序号 |
标题 |
次数 |
作者 |
发布时间 |
66601 |
NOTA-C6-amine,NOTA-C6-氨基 |
97 |
h |
2024-12-23 |
66602 |
Me-Diazirine-C7-OH,1823865-63-9,甲基-双吖丙啶-C7-羟基 |
87 |
h |
2024-12-23 |
66603 |
m-PEG12-C11-SH,甲基-十二聚乙二醇-C11-巯基 |
78 |
h |
2024-12-23 |
66604 |
m-PEG4-C11-SH,200880-89-3,甲基-四聚乙二醇-C11-巯基 |
114 |
h |
2024-12-23 |
66605 |
m-PEG8-C11-SH,甲基-八聚乙二醇-C11-巯基 |
73 |
h |
2024-12-23 |
66606 |
(S,R,S)-AHPC-C10-NH2,CAS:2341796-74-3,(S,R,S)-AHPC-C10-胺 |
108 |
h |
2024-12-23 |
66607 |
(S,R,S)-AHPC-C9-azide,2906183-84-2,(S,R,S)-AHPC-C9-叠氮 |
110 |
h |
2024-12-23 |
66608 |
(S,R,S)-AHPC-C8-azide,2906183-83-1,(S,R,S)-AHPC-C8-叠氮 |
139 |
h |
2024-12-20 |
66609 |
m-PEG9-(CH2)8-Phosphonic acid,2900307-00-6,甲基-九聚乙二醇-C8-膦酸 |
120 |
h |
2024-12-20 |
66610 |
m-PEG2-(CH2)8-Phosphonic acid,2227008-55-9,甲基-二聚乙二醇-C8-膦酸 |
123 |
h |
2024-12-20 |
66611 |
m-PEGn-(CH2)8-Phosphonic acid,甲基-聚乙二醇-C8-膦酸 |
144 |
h |
2024-12-20 |
66612 |
Bio-PEG3-C14-鞘氨醇,生物-三聚乙二醇-C14-鞘氨醇 |
90 |
h |
2024-12-20 |
66613 |
NHS-C16-COOH,146004-84-4,琥珀酰亚胺酯-C16-酸 |
151 |
h |
2024-12-20 |
66614 |
DBCO-CONH-PEG4-Maleimide |
94 |
h |
2024-12-20 |
66615 |
cas:2130869-17-7,VCP-Eribulin , ADC试剂 |
79 |
kx |
2024-12-20 |
66616 |
cas:452072-20-7,SPP-DM1 ,抗体药物偶联物(ADC) |
107 |
kx |
2024-12-20 |
66617 |
1810001-93-4,DBM-MMAF,抗体药物偶联物(ADC) |
157 |
kx |
2024-12-20 |
66618 |
Fmoc-Gln(Trt)-PAB-PNP, ADC试剂 |
119 |
kx |
2024-12-20 |
66619 |
cas:330970-70-2,Alloc-Val-Ala-OH,((烯丙氧基)羰基)-L-戊基-L-丙氨酸 |
122 |
kx |
2024-12-20 |
66620 |
cas:2055041-40-0,Azido-PEG1-Val-Cit-PAB-OH, ADC试剂 |
77 |
kx |
2024-12-20 |
66621 |
DBCO-C4-Val-Cit-PABC-PNP,抗体药物偶联物(ADC) |
114 |
kx |
2024-12-20 |
66622 |
cas:2243566-44-9,Azidoethyl-SS-propionic NHS ester,叠氮-二硫键-琥珀酰亚胺酯 |
134 |
kx |
2024-12-20 |
66623 |
MEL-tri-EG-OPFP,抗体药物偶联物(ADC) |
176 |
kx |
2024-12-20 |
66624 |
Pomalidomide-C6-COOH,2225940-50-9 |
80 |
wyh |
2024-12-20 |
66625 |
cas:799840-96-3,Maytansinoid DM4,N2'-去乙酰基-N2'-(4-巯基-4-甲基-1-氧代戊基)-6-甲基美登素 |
132 |
kx |
2024-12-20 |
66626 |
Cl-C6-PEG1-O-CH2COOH,2231744-57-1,氯-C6-一聚乙二醇-O-乙酸 |
86 |
wyh |
2024-12-20 |
66627 |
Amino-PEG1-C6 (HCl salt),1802310-46-8 |
95 |
wyh |
2024-12-20 |
66628 |
cas:114390-30-6,N-(Iodoacetamido)-Doxorubicin, ADC试剂 |
119 |
kx |
2024-12-20 |
66629 |
Azido-PEG5-C6-Cl,1261238-21-4,叠氮-五聚乙二醇-C6-氯 |
89 |
wyh |
2024-12-20 |
66630 |
cas:1226050-10-7,N-(2-(4-Chlorophenoxy)ethyl)-4-formylbenzamide |
131 |
kx |
2024-12-20 |
66631 |
DBCO-C3-Maleimide,1629057-08-4 |
106 |
h |
2024-12-20 |
66632 |
cas:663599-00-6,NO2-SPDMV-sulfo, ADC试剂 |
103 |
kx |
2024-12-20 |
66633 |
CAS:118162-45-1 N3-C10-COOH 叠氮-C10-酸 |
110 |
h |
2024-12-20 |
66634 |
Biotin-PEG-C14 生物素聚乙二醇C14 |
92 |
h |
2024-12-20 |
66635 |
NH2-PEG2000-C16 palmitic acid 氨基-聚乙二醇-棕榈酸 |
67 |
h |
2024-12-20 |
66636 |
cas:1428629-70-2,Propargyl-PEG4-NHS ester,丙炔基-三聚乙二醇-丙烯酸琥珀酰亚胺酯 |
161 |
kx |
2024-12-20 |
66637 |
DBCO-C16 palmitic acid 二苯并环辛炔-聚乙二醇-棕榈酸 |
104 |
h |
2024-12-20 |
66638 |
mPEG2000-sese-C16 甲氧基PEG双硒键棕榈酸 |
105 |
h |
2024-12-20 |
66639 |
cas:874302-76-8,PDEC-NB, 4-硝基苯基2-(吡啶-2-基二硫烷基)乙基碳酸酯 |
85 |
kx |
2024-12-20 |
66640 |
C16-PEG-NHS 棕榈酸聚乙二醇活性酯 |
117 |
h |
2024-12-20 |
66641 |
cas:1492056-71-9,Amino-PEG4-Val-Cit-PAB-MMAE,抗体药物偶联物(ADC) |
111 |
kx |
2024-12-20 |
66642 |
胆固醇-聚乙二醇-CY5 Chol-PEG-CY5 |
100 |
h |
2024-12-20 |
66643 |
NH2-PEG5000-C18 Stearic Acid 氨基-聚乙二醇-硬脂酸 |
80 |
h |
2024-12-20 |
66644 |
NH2-PEG350-C18 Stearic Acid 氨基-聚乙二醇-硬脂酸 |
119 |
h |
2024-12-20 |
66645 |
Anti-TNFRSF8 (Brentuximab)-VC-PAB-MMAE,抗体药物偶联物(ADC) |
82 |
kx |
2024-12-20 |